More vaccines enter Phase III trials, researchers are learning more about the long-term impact of Covid-19, and risk calculation becomes increasingly difficult as the country reopens – Tech in Two.
What's New - En podkast av WIRED
Kategorier:
Catch up on the most important news today in 2 minutes or less. Get even more news you can use with the Tech in Two newsletter. Sign up here: https://www.wired.com/tt
